Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.

Alexis OgdieKurt de VlamIain B McInnes Phillip J MeasePhilip BaerTatjana LukicDavid GrubenKenneth KwokCunshan WangMing-Ann HsuAnna Maniccia

Published in: RMD open (2021)

Tofacitinib was associated with rapid and sustained improvements across multiple pain measures in patients with inflammatory rheumatic musculoskeletal diseases.

Keyphrases

rheumatoid arthritis
ankylosing spondylitis
chronic pain
disease activity
pain management
neuropathic pain
ulcerative colitis
oxidative stress
spinal cord injury
systemic lupus erythematosus
postoperative pain
quantum dots